Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer

Copy For Citation

VOLKAN M., GÜRAY N. T., Asik E., Lopez-Berestein G., Ozpolat B., Kahraman N.

AACR, 1 - 05 April 2017, vol.77, pp.1125

• Publication Type: Conference Paper / Summary Text
• Volume: 77
• Doi Number: 10.1158/1538-7445.am2017-1125
• Page Numbers: pp.1125
• Middle East Technical University Affiliated: Yes